Your browser doesn't support javascript.
loading
CA19.9 Response and Tumor Size Predict Recurrence Following Post-neoadjuvant Pancreatectomy in Initially Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma.
Maggino, Laura; Malleo, Giuseppe; Crippa, Stefano; Belfiori, Giulio; Nobile, Sara; Gasparini, Giulia; Lionetto, Gabriella; Luchini, Claudio; Mattiolo, Paola; Schiavo-Lena, Marco; Doglioni, Claudio; Scarpa, Aldo; Bassi, Claudio; Falconi, Massimo; Salvia, Roberto.
Afiliação
  • Maggino L; Unit of General and Pancreatic Surgery, Department of Surgery and Oncology, University of Verona Hospital Trust, G.B. Rossi Hospital, Verona, Italy.
  • Malleo G; Unit of General and Pancreatic Surgery, Department of Surgery and Oncology, University of Verona Hospital Trust, G.B. Rossi Hospital, Verona, Italy.
  • Crippa S; Unit of Pancreatic Surgery, Pancreas Translational and Clinical Research Center, San Raffaele Scientific Institute, Vita-Salute University, Milan, Italy.
  • Belfiori G; Unit of Pancreatic Surgery, Pancreas Translational and Clinical Research Center, San Raffaele Scientific Institute, Vita-Salute University, Milan, Italy.
  • Nobile S; Unit of General and Pancreatic Surgery, Department of Surgery and Oncology, University of Verona Hospital Trust, G.B. Rossi Hospital, Verona, Italy.
  • Gasparini G; Unit of Pancreatic Surgery, Pancreas Translational and Clinical Research Center, San Raffaele Scientific Institute, Vita-Salute University, Milan, Italy.
  • Lionetto G; Unit of General and Pancreatic Surgery, Department of Surgery and Oncology, University of Verona Hospital Trust, G.B. Rossi Hospital, Verona, Italy.
  • Luchini C; Department of Diagnostics and Public Health, Section of Pathology, University of Verona Hospital Trust, Verona, Italy.
  • Mattiolo P; Department of Diagnostics and Public Health, Section of Pathology, University of Verona Hospital Trust, Verona, Italy.
  • Schiavo-Lena M; Division of Pathology, Pancreas Translational and Clinical Research Center, Vita-Salute University, San Raffaele Scientific Institute, Milan, Italy.
  • Doglioni C; Division of Pathology, Pancreas Translational and Clinical Research Center, Vita-Salute University, San Raffaele Scientific Institute, Milan, Italy.
  • Scarpa A; Department of Diagnostics and Public Health, Section of Pathology, University of Verona Hospital Trust, Verona, Italy.
  • Bassi C; Unit of General and Pancreatic Surgery, Department of Surgery and Oncology, University of Verona Hospital Trust, G.B. Rossi Hospital, Verona, Italy.
  • Falconi M; Unit of Pancreatic Surgery, Pancreas Translational and Clinical Research Center, San Raffaele Scientific Institute, Vita-Salute University, Milan, Italy.
  • Salvia R; Unit of General and Pancreatic Surgery, Department of Surgery and Oncology, University of Verona Hospital Trust, G.B. Rossi Hospital, Verona, Italy. roberto.salvia@univr.it.
Ann Surg Oncol ; 30(1): 207-219, 2023 Jan.
Article em En | MEDLINE | ID: mdl-36227391
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Ann Surg Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Itália

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Ann Surg Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Itália